Skip to main content
Fig. 7 | BMC Cancer

Fig. 7

From: Impact of AADAC gene expression on prognosis in patients with Borrmann type III advanced gastric cancer

Fig. 7

a Nomogram models predicting the disease free survival of patients a Nomogram model predicting the 3- and 5-year disease-free survival of patients with Borrmann type III AGC. b ROC curve of the nomogram model predicting the 3-year disease-free survival of patients. c ROC curve of the nomogram model predicting the 5-year disease-free survival of patients. ROC: receiver operating characteristic, CA19-9: carbohydrate antigen 19-9

Back to article page